<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to investigate the relationship between total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels in people with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and cognitive status </plain></SENT>
<SENT sid="1" pm="."><plain>Fifty patients from our <z:mp ids='MP_0002055'>diabetes</z:mp> unit (30 females/20 males) with <z:mp ids='MP_0002055'>diabetes</z:mp> were enrolled </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had fasting blood samples taken for measurement of <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>; total cholesterol and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> concentrations and other <z:chebi fb="23" ids="18059">lipid</z:chebi> fractions (<z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a), <z:chebi fb="2" ids="39026">low density lipoprotein</z:chebi> (<z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>), <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> (<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>)), <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA(1c) and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>24-h urine collection was used to measure <z:chebi fb="0" ids="16737">creatinine</z:chebi> clearance and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="9" ids="17439">Vitamin B-12</z:chebi> and <z:chebi fb="3" ids="37445">folate</z:chebi> were measured to assess vitamin status </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> diabetic patients were assessed for late complications and a Mini-Mental State Examination (MMSE) was performed </plain></SENT>
<SENT sid="6" pm="."><plain>The patients were 64.6 (49-78) years old with body mass index (BMI) of 29.6 +/- 6.3 kg/m(2), and duration of <z:mp ids='MP_0002055'>diabetes</z:mp> of 8.9 +/- 6.7 years </plain></SENT>
<SENT sid="7" pm="."><plain>A univariant correlation analysis was performed among <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> and vitamins with total MMSE score </plain></SENT>
<SENT sid="8" pm="."><plain>Total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> was inverse by correlated with MMSE score (r=-0.38; P&lt;0.05) of the other measures of cardiovascular risk, <z:mp ids='MP_0002959'>microalbuminuria</z:mp> showed an inverse correlation with MMSE score (r=-0.51:P&lt;0.01) </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="2" ids="6495">Lipoproteins</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi> control and vitamin status were not correlated MMSE score </plain></SENT>
<SENT sid="10" pm="."><plain>In the multiple regression model only <z:mp ids='MP_0002959'>microalbuminuria</z:mp> remained in the model, showing a decrease of one point in the MMSE result with each milligram of <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, adjusted for confounding factors </plain></SENT>
<SENT sid="11" pm="."><plain>Cognitive status in type 2 diabetic was correlated with <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels and <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, this last endothelial damage marker remaining as an independent risk factor of <z:e sem="disease" ids="C0854193" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive deterioration</z:e> </plain></SENT>
</text></document>